Events Search and Views Navigation
June 2016
DIA 52nd Annual Meeting
“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).
Find out more »September 2016
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
Find out more »October 2016
2016 Cell & Gene Meeting on the Mesa
“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)
Find out more »November 2016
Address by Gerald J. Dal Pan, MD, MHS
The FDA’s Director of the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research will deliver the address, “Assessing the Impact of Postmarketing Regulatory Programs and Actions.” Please note that participation is by invitation only.
Find out more »December 2016
The Drug Development Paradigm in Oncology
hosted by the National Cancer Policy Forum. (G.K. Raju)
Find out more »January 2017
DIA Integrated Adaptive Development and Decision Making Conference
(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)
Find out more »April 2017
Cell & Gene Therapy Investor Day
(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges
Find out more »May 2017
Leaders In Global Healthcare & Technology (LIGHT)
(Gigi Hirsch) Panel: Real World Evidence: Hype or Reality? (John Glasspool, Moderator)
Find out more »Blue Cross Blue Shield National Council of Physician and Pharmacy Executives
(Mark Trusheim) Adaptive Pathways and Platform Trials Discussion
Find out more »July 2017
Partnering for Cures
(Gigi Hirsch) Panel: Getting What You Measure: Incentives for Collaboration
Find out more »